Page last updated: 2024-10-25

deferoxamine and Carcinoma, Basal Cell

deferoxamine has been researched along with Carcinoma, Basal Cell in 3 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Carcinoma, Basal Cell: A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choudry, K1
Brooke, RC1
Farrar, W1
Rhodes, LE1
Fijan, S1
Hönigsmann, H1
Ortel, B1
Ninomiya, Y1
Itoh, Y1
Henta, T1
Ishibashi, A1

Trials

1 trial available for deferoxamine and Carcinoma, Basal Cell

ArticleYear
The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
    The British journal of dermatology, 2003, Volume: 149, Issue:1

    Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Car

2003

Other Studies

2 other studies available for deferoxamine and Carcinoma, Basal Cell

ArticleYear
Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine.
    The British journal of dermatology, 1995, Volume: 133, Issue:2

    Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Deferoxamine; Female; Humans; Keratosis

1995
Photodynamic diagnosis of basal cell carcinoma on the lower eyelid using topical 5-aminolaevulinic acid and desferrioxamine.
    The British journal of dermatology, 1999, Volume: 141, Issue:3

    Topics: Adult; Aminolevulinic Acid; Carcinoma, Basal Cell; Deferoxamine; Eyelid Neoplasms; Humans; Male; Pho

1999